Literature DB >> 18528630

Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats.

C Marin1, E Aguilar, M Bonastre.   

Abstract

Parkinson's disease (PD) is characterized not only by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) but also by a degeneration of locus coeruleus (LC) noradrenergic neurons. It has been suggested that deficient LC noradrenergic mechanisms might play a critical role in symptomatology and in the progression of PD. However, the effect of LC depletion on levodopa-induced motor complications, such as the motor fluctuations, is still unknown. Male Sprague-Dawley rats received 50 mg/kg intraperitoneal (i.p.) of [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) or saline 7 days before the day of 6-hydroxydopamine (6-OHDA, 8 microg) administration in the medial forebrain bundle. Four weeks later, animals were treated with levodopa (25 mg/kg with benserazide, twice at day, i.p.) for 22 days. Rotational behavior was measured on days 1 and 22 of levodopa administration. Tyrosine hydroxylase (TH) immunohistochemistry was performed to evaluate the neurodegeneration in the SNc and LC. Striatal dopamine transporter (DAT) immunohistochemistry was performed to evaluate DA depletion. As expected, levodopa administration decreased the duration of the motor response in the vehicle-pretreated group (P < 0.01). A potentiation of levodopa-induced shortening in the duration of motor response was not achieved after LC depletion since no significant differences were observed in the duration of rotational behavior between these two groups on day 22. In addition, LC depletion did not potentiate either the total number of rotations or the maximal peak of rotation induced by levodopa treatment. These results suggest that LC depletion might not be involved in the pathophysiology of levodopa-induced motor fluctuations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528630     DOI: 10.1007/s00702-008-0060-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  48 in total

1.  Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.

Authors:  A J Lategan; M R Marien; F C Colpaert
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

2.  Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.

Authors:  C Pifl; G Schingnitz; O Hornykiewicz
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

3.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  Biochemical pathophysiology of Parkinson's disease.

Authors:  O Hornykiewicz; S J Kish
Journal:  Adv Neurol       Date:  1987

5.  Where does parkinson disease pathology begin in the brain?

Authors:  Kelly Del Tredici; Udo Rüb; Rob A I De Vos; Jürgen R E Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-05       Impact factor: 3.685

6.  Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.

Authors:  M Marien; M Briley; F Colpaert
Journal:  Eur J Pharmacol       Date:  1993-06-04       Impact factor: 4.432

7.  Pharmacological basis of akinesia in Parkinson's disease.

Authors:  H Narabayashi
Journal:  J Neural Transm Suppl       Date:  1983

Review 8.  Noradrenergic mechanisms in neurodegenerative diseases: a theory.

Authors:  Marc R Marien; Francis C Colpaert; Alan C Rosenquist
Journal:  Brain Res Brain Res Rev       Date:  2004-04

9.  Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.

Authors:  J M Fritschy; R Grzanna
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.

Authors:  P Chopin; F C Colpaert; M Marien
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  7 in total

1.  Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.

Authors:  Xingxing Jin; Kerstin Schwabe; Joachim K Krauss; Mesbah Alam
Journal:  Exp Brain Res       Date:  2016-01-02       Impact factor: 1.972

Review 2.  Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Charlene Le Gal; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

3.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.

Authors:  Ariana Q Farrand; Kristi L Helke; Rebecca A Gregory; Monika Gooz; Vanessa K Hinson; Heather A Boger
Journal:  Brain Stimul       Date:  2017-08-24       Impact factor: 8.955

4.  Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Authors:  Christopher J Barnum; Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Stefanie Tignor; Anna Klioueva; Hannah Walters; Christopher Bishop
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

5.  Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.

Authors:  V Pérez; C Marin; A Rubio; E Aguilar; M Barbanoj; J Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2009-08-27       Impact factor: 3.575

6.  Noradrenergic modulation of the motor response induced by long-term levodopa administration in Parkinsonian rats.

Authors:  Virgili Pérez; Victoria Sosti; Antonia Rubio; Manel Barbanoj; Ignasi Gich; José Rodríguez-Alvarez; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2009-05-26       Impact factor: 3.575

7.  The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.

Authors:  Cristina Miguelez; Asier Aristieta; Maria Angela Cenci; Luisa Ugedo
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.